Back

Metabolic dysfunction-associated steatotic liver disease (MASLD)

20 February 2026 (16:50 - 17:30)
Organised by: Logo
Seminar Presentation Part of: Therapeutic management (part II) Pharmacotherapy, Other Delegate Premium access EAPC Course : Cardiometabolic Syndrome, Diabetes and Obesity European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Professor Amalia Gastaldelli

CNR – National Research Council, Pisa (Italy)

2 More presentations in this session

Presentation thumbnail
Managing chronic kidney disease
Professor P. Groop (Helsinki, FI)
Slides Video
Presentation thumbnail
Panel discussion

Access the full session

Session thumbnail
Therapeutic management (part II)

The Event

Event poster

EAPC Course : Cardiometabolic Syndrome, Diabetes and Obesity

20 February 2026 16:50 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac structure and function in patients with MASLD varies by liver fibrosis severity
31 August 2025
thumbnail
Congress Presentation
Antihypertensive drugs in experimental NAFLD as the first step to the establishment of criteria for choosing appropriate treatment of hypertension in NAFLD carriers
2 September 2019
thumbnail
Congress Presentation
impact of different cardiometabolic risk factors in MASLD: rethinking overweight/obesity criteria.
26 April 2024
thumbnail
Congress Presentation
Prevalence of non-alcoholic fatty liver disease measured by controlled attenuation parameter in patients with heart failure according to the left ventricular ejection fraction
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources